Work

Recombinant G-CSF-ApoAI Fusion Protein Is a Pleiotropic Factor

Year: 2025
Type: article
Abstract: . Using human bone marrow cells, the fusion protein was shown to retain the granulocyte activity of authentic G-CSF, more effectively inducing the differentiation and maturation of segmented neutrophils and maintaining the viability of progenitor cells. Using human mononuclear cells and THP cells, the resulting protein demonstrated monocytic activity, manifested by an increase in both total and CD14+ cell counts. By maintaining cell viability, the chimeric protein reduced the number of cells expressing caspase 3/7. G-CSF-ApoAI demonstrated accelerated cytokine regulation, promoting a more rapid transition of inflammation phases, accompanied by increased phagocytosis of latex particles, compared with G-CSF, increasing phagocytosis by 1.4-fold in the LPS-induced inflammation model. This suggests that this new pleotropic factor may be useful for pathogen clearance in infected wounds.
Source: Molecules
Language: English
Subfield: Rehabilitation
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,258
OpenAlex ID: W7117741324
FWCI:
Cites: 35
Cited by:
Related to: